CHK
35
8
SJM
41
8
VLO
45
3
AZO
43
-2
NWSA
49
2
CCI
30
-6
CTAS
58
2
O
28
-7
MLM
58
5
CL
56
-2
AMT
55
-3
CSCO
51
4
BF.B
50
-7
MSFT
57
3
MRO
55
4
BWA
49
7
TDC
49
2
MS
57
7
CAG
36
-3
M
17
3
CHK
35
8
SJM
41
8
VLO
45
3
AZO
43
-2
NWSA
49
2
CCI
30
-6
CTAS
58
2
O
28
-7
MLM
58
5
CL
56
-2
AMT
55
-3
CSCO
51
4
BF.B
50
-7
MSFT
57
3
MRO
55
4
BWA
49
7
TDC
49
2
MS
57
7
CAG
36
-3
M
17
3
Financhill
Back

180 Life Sciences Quote, Financials, Valuation and Earnings

Free 23-page book shares my #1 indicator to use

Here's the 23-page free book.
Sell
29

ATNF
180 Life Sciences

Last Price:
1.94
Seasonality Move:
-32.84%

7 Day Trial

ALL ACCESS PASS

$ 7

How to Profit From "America's Earnings" Reports

New Trade Goes LIVE THIS TUESDAY at 2 pm

180 Life Sciences Price Quote

$1.94
+0.00 (+0.01%)
(Updated: September 20, 2024 at 3:20 PM ET)

180 Life Sciences Key Stats

Sell
29
180 Life Sciences (ATNF) is a Sell
Day range:
$1.86 - $2.02
52-week range:
$1.31 - $13.41
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%
Volume:
25.1K
Avg. volume:
57.4K
1-year change:
-84.18%
Market cap:
$1.9M
Revenue:
$0
EPS:
$-28.47

How Much Does 180 Life Sciences Make?

Data Unavailable

Is 180 Life Sciences Growing As A Company?

Data Unavailable

180 Life Sciences Stock Price Performance

What Is 180 Life Sciences 52-Week High & Low?

180 Life Sciences Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy 180 Life Sciences?

  • How Much Debt Does 180 Life Sciences Have?
    Total long term debt quarterly is $0
  • How Much Cash Does 180 Life Sciences Have?
    Cash and short term investments quarterly total is $1.1M
  • What Is 180 Life Sciences’s Book Value Per Share?
    Book value per share is -0.44

Is 180 Life Sciences Cash Flow Positive?

  • What Is ATNF Cash Flow From Operations?
    Cash flow from operations (TTM) is -$4.2M
  • What Is 180 Life Sciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $3.4M
  • What Is 180 Life Sciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

180 Life Sciences Return On Invested Capital

Data Unavailable

180 Life Sciences Earnings Date & Stock Price

180 Life Sciences Competitors

  • Who Are 180 Life Sciences's Competitors?
    Below is a list of companies who compete with 180 Life Sciences or are related in some way:
    • iBio Inc (IBIO)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Palatin Technologies Inc (PTN)
    • Seelos Therapeutics Inc (SEEL)
    • Theriva Biologics Inc (TOVX)

180 Life Sciences Dividend Yield

180 Life Sciences Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 32.7%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 1,520.00
Upside from Last Price: 78254.52%

Major Shareholders

  • How many ATNF shares are owned by institutional investors?
    16.9K ATNF shares are owned by institutional investors
  • How many ATNF shares are owned by insiders?
    562.9K ATNF shares are owned by insiders